BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moncunill G, Scholzen A, Mpina M, Nhabomba A, Hounkpatin AB, Osaba L, Valls R, Campo JJ, Sanz H, Jairoce C, Williams NA, Pasini EM, Arteta D, Maynou J, Palacios L, Duran-frigola M, Aponte JJ, Kocken CHM, Agnandji ST, Mas JM, Mordmüller B, Daubenberger C, Sauerwein R, Dobaño C. Antigen-stimulated PBMC transcriptional protective signatures for malaria immunization. Sci Transl Med 2020;12:eaay8924. [DOI: 10.1126/scitranslmed.aay8924] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Gomez MA, Belew AT, Navas A, Rosales-Chilama M, Murillo J, Dillon LAL, Alexander TA, Martinez-Valencia A, El-Sayed NM. Early Leukocyte Responses in Ex-Vivo Models of Healing and Non-Healing Human Leishmania (Viannia) panamensis Infections. Front Cell Infect Microbiol 2021;11:687607. [PMID: 34557423 DOI: 10.3389/fcimb.2021.687607] [Reference Citation Analysis]
2 Neal ML, Duffy FJ, Du Y, Aitchison JD, Stuart KD. Preimmunization correlates of protection shared across malaria vaccine trials in adults. NPJ Vaccines 2022;7:5. [PMID: 35031601 DOI: 10.1038/s41541-021-00425-1] [Reference Citation Analysis]
3 Dumonteil E, Herrera C. The Case for the Development of a Chagas Disease Vaccine: Why? How? When? Trop Med Infect Dis 2021;6:16. [PMID: 33530605 DOI: 10.3390/tropicalmed6010016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Seaton KE, Spreng RL, Abraha M, Reichartz M, Rojas M, Feely F 2nd, Huntwork RHC, Dutta S, Mudrak SV, Alam SM, Gregory S, Jongert E, Coccia M, Ulloa-Montoya F, Wille-Reece U, Tomaras GD, Dennison SM. Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection. NPJ Vaccines 2021;6:110. [PMID: 34462438 DOI: 10.1038/s41541-021-00372-x] [Reference Citation Analysis]
5 Stanisic DI, McCall MBB. Correlates of malaria vaccine efficacy. Expert Rev Vaccines 2021;20:143-61. [PMID: 33499692 DOI: 10.1080/14760584.2021.1882309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Moncunill G, Carnes J, Chad Young W, Carpp L, De Rosa S, Campo JJ, Nhabomba A, Mpina M, Jairoce C, Finak G, Haas P, Muriel C, Van P, Sanz H, Dutta S, Mordmüller B, Agnandji ST, Díez-padrisa N, Williams NA, Aponte JJ, Valim C, Neafsey DE, Daubenberger C, Mcelrath MJ, Dobaño C, Stuart K, Gottardo R. Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case–control study. eLife 2022;11:e70393. [DOI: 10.7554/elife.70393] [Reference Citation Analysis]
7 Coban C. The host targeting effect of chloroquine in malaria. Curr Opin Immunol 2020;66:98-107. [PMID: 32823144 DOI: 10.1016/j.coi.2020.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
8 Matorras R, Valls R, Azkargorta M, Burgos J, Rabanal A, Elortza F, Mas JM, Sardon T. Proteomics based drug repositioning applied to improve in vitro fertilization implantation: an artificial intelligence model. Syst Biol Reprod Med 2021;67:281-97. [PMID: 34126818 DOI: 10.1080/19396368.2021.1928792] [Reference Citation Analysis]
9 Nyarko PB, Claessens A. Understanding Host-Pathogen-Vector Interactions with Chronic Asymptomatic Malaria Infections. Trends Parasitol 2021;37:195-204. [PMID: 33127332 DOI: 10.1016/j.pt.2020.09.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]